Literature DB >> 92816

Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine.

A Szczeklik, M Serwonska.   

Abstract

An H1-receptor blocking antihistamine, clemastine, taken before aspirin gave complete or partial protection against flushing, rhinorrhea, cough, and headache in ten asthmatic patients with idiosyncrasy to aspirin. In five of the ten patients aspirin-precipitated bronchoconstriction was also reduced or prevented after pretreatment with clemastine. Thus histamine appears to play a part in the production of most non-respiratory symptoms occurring after aspirin ingestion in intolerant patients with asthma. Bronchial reactions might depend partly on histamine and partly on the action of other spasmogens. It is suggested that inhibition of prostaglandins of the E series by aspirin-like drugs plays a crucial part in the release of histamine from tissue stores in aspirin-sensitive asthmatic patients. Clemastine might be of use in the treatment of acute reactions to aspirin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92816      PMCID: PMC471141          DOI: 10.1136/thx.34.5.654

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

2.  Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis.

Authors:  A Szczeklik; R J Gryglewski; G Czerniawska-Mysik
Journal:  J Allergy Clin Immunol       Date:  1977-11       Impact factor: 10.793

3.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Authors:  M Samter; R F Beers
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

Review 4.  Immunologic release of chemical mediators from human tissues.

Authors:  M Kaliner; K F Austen
Journal:  Annu Rev Pharmacol       Date:  1975       Impact factor: 13.820

5.  Effect of alpha-receptor blocking drugs and disodium cromoglyate on histamine hypersensitivity in bronchial asthma.

Authors:  J W Kerr; M Govindaraj; K R Patel
Journal:  Br Med J       Date:  1970-04-18

6.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

7.  Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation.

Authors:  N A Martelli; G Usandivaras
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

8.  Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients.

Authors:  M Pasargiklian; S Bianco; L Allegra; N E Moavero; G Petrigni; M Robuschi; A Grugni
Journal:  Respiration       Date:  1977       Impact factor: 3.580

9.  Cromolyn sodium in the treatment of asthma associated with aspirin hypersensitivity and nasal polyps.

Authors:  E Gwin; G R Kerby; W E Ruth
Journal:  Chest       Date:  1977-08       Impact factor: 9.410

10.  Effect on airways resistance of prostaglandin E1 given by aerosol to healthy and asthmatic volunteers.

Authors:  M F Cuthbert
Journal:  Br Med J       Date:  1969-12-20
View more
  11 in total

Review 1.  Natural history and clinical features of aspirin-exacerbated respiratory disease.

Authors:  John M Fahrenholz
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 2.  Pathogenesis of aspirin-exacerbated respiratory disease.

Authors:  Donald D Stevenson; Bruce L Zuraw
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 3.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

Review 4.  Rhinosinusitis: Establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  Otolaryngol Head Neck Surg       Date:  2004-12       Impact factor: 3.497

Review 5.  Rhinosinusitis: establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

6.  Ketorolac-induced bronchospasm in an aspirin-intolerant patient.

Authors:  A H Chen; C R Bennett
Journal:  Anesth Prog       Date:  1994

Review 7.  Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs).

Authors:  Ronald A Simon; Jennifer Namazy
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 8.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 9.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 10.  The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.

Authors:  Whitney W Stevens; Elina Jerschow; Alan P Baptist; Larry Borish; John V Bosso; Kathleen M Buchheit; Katherine N Cahill; Paloma Campo; Seong H Cho; Anjeni Keswani; Joshua M Levy; Anil Nanda; Tanya M Laidlaw; Andrew A White
Journal:  J Allergy Clin Immunol       Date:  2020-12-09       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.